Factors associated with failure of using high flow nasal cannula in children

Kanokkarn Sunkonkit, Supakanya Kungsuwan, Sukanlaya Seetaboot, Sanit Reungrongrat, Kanokkarn Sunkonkit, Supakanya Kungsuwan, Sukanlaya Seetaboot, Sanit Reungrongrat

Abstract

Introduction: High flow nasal cannula (HFNC) has significantly success in treating acute respiratory distress while HFNC failure dramatically increases mortality and morbidity.

Objective: To describe factors associated with failure of HFNC use in children.

Methods: We performed a retrospective observational study using demographic and laboratory findings. We compared clinical and laboratory variables in both successful and failed HFNC groups. The correlations between factors and HFNC failure were constructed by binary logistic regression analysis.

Results: Between August 2016 and May 2018, 250 children receiving HFNC (median age 16 months; range 1-228 months, male 50.8%) were enrolled. Pneumonia was the most common cause of respiratory distress, and the median length of stay (LOS) in hospital was 11 days. HFNC failure was found 16.4% while HFNC complication was 4.8% including epistaxis, pressure sore, and gastric distension. Based on multivariable logistic regression analysis, factors associated with HFNC failure were children with congenital heart disease comorbidity (p = 0.005), HFNC use with maximum FiO2 > 0.6 (p = 0.021), lobar infiltration on chest X-ray (p = 0.012), the reduction of heart rate, and respiratory rate <20% after 1 h of HFNC use (p = 0.001 and p = 0.001, respectively).

Conclusion: HFNC is feasible to use for children with respiratory distress; however, patients with congenital heart disease, using HFNC with FiO2 > 0.6, lobar infiltration on chest X-ray should be closely monitored. Heart rate and respiratory rate are important parameters in addition to clinical assessment for evaluating HFNC failure in children.

Keywords: children; high flow nasal cannula; non-invasive ventilation; respiratory support.

Conflict of interest statement

The authors declare no conflict of interest.

© 2022 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd.

References

    1. Mikalsen IB, Davis P, Øymar K. High flow nasal cannula in children: a literature review. Scand J Trauma Resusc Emerg Med. 2016;24(1):1‐12. doi:10.1186/s13049-016-0278-4
    1. Milési C, Boubal M, Jacquot A, et al. High‐flow nasal cannula: recommendations for daily practice in pediatrics. Ann Intensive Care. 2014;4(1):1‐7. doi:10.1186/s13613-014-0029-5
    1. Roca O, Riera J, Torres F, Masclans JR. High‐flow oxygen therapy in acute respiratory failure. Respir Care. 2010;55(4):408‐413.
    1. Kwon JW. High‐flow nasal cannula oxygen therapy in children: a clinical review. Clin Exp Pediatr. 2020;63(1):3‐7. doi:10.3345/kjp.2019.00626
    1. Mayfield S, Jauncey‐Cooke J, Hough JL, Schibler A, Gibbons K, Bogossian F. High‐flow nasal cannula therapy for respiratory support in children. Cochrane Database Syst Rev. 2014;2014 (3):Cd009850.
    1. Chao KY, Chien YH, Mu SC. High‐flow nasal cannula in children with asthma exacerbation: a review of current evidence. Paediatr Respir Rev. 2021;40:52‐57. doi:10.1016/j.prrv.2021.01.003
    1. Nishimura M. High‐flow nasal cannula oxygen therapy devices. Respir Care. 2019;64(6):735‐742. doi:10.4187/respcare.06718
    1. Slain KN, Shein SL, Rotta AT. The use of high‐flow nasal cannula in the pediatric emergency department. J Pediatr (Rio J). 2017;93(Suppl 1):36‐45. doi:10.1016/j.jped.2017.06.006
    1. Dysart K, Miller TL, Wolfson MR, Shaffer TH. Research in high flow therapy: mechanisms of action. Respir Med. 2009;103(10):1400‐1405. doi:10.1016/j.rmed.2009.04.007
    1. Hasani A, Chapman TH, McCool D, Smith RE, Dilworth JP, Agnew JE. Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis. Chron Respir Dis. 2008;5(2):81‐86. doi:10.1177/1479972307087190
    1. Williams R, Rankin N, Smith T, Galler D, Seakins P. Relationship between the humidity and temperature of inspired gas and the function of the airway mucosa. Crit Care Med. 1996;24(11):1920‐1929. doi:10.1097/00003246-199611000-00025
    1. Lampland AL, Plumm B, Meyers PA, Worwa CT, Mammel MC. Observational study of humidified high‐flow nasal cannula compared with nasal continuous positive airway pressure. J Pediatr. 2009;154(2):177‐182. doi:10.1016/j.jpeds.2008.07.021
    1. Spence KL, Murphy D, Kilian C, McGonigle R, Kilani RA. High‐flow nasal cannula as a device to provide continuous positive airway pressure in infants. J Perinatol. 2007;27(12):772‐775. doi:10.1038/sj.jp.7211828
    1. Wing R, James C, Maranda LS, Armsby CC. Use of high‐flow nasal cannula support in the emergency department reduces the need for intubation in pediatric acute respiratory insufficiency. Pediatr Emerg Care. 2012;28(11):1117‐1123. doi:10.1097/PEC.0b013e31827122a9
    1. McKiernan C, Chua LC, Visintainer PF, Allen H. High flow nasal cannulae therapy in infants with bronchiolitis. J Pediatr. 2010;156(4):634‐638. doi:10.1016/j.jpeds.2009.10.039
    1. Schibler A, Pham TM, Dunster KR, et al. Reduced intubation rates for infants after introduction of high‐flow nasal prong oxygen delivery. Intensive Care Med. 2011;37(5):847‐852. doi:10.1007/s00134-011-2177-5
    1. Inoue S, Tamaki Y, Sonobe S, Egawa J, Kawaguchi M. A pediatric case developing critical abdominal distension caused by a combination of humidified high‐flow nasal cannula oxygen therapy and nasal airway. JA Clin Rep. 2018;4(1):1‐3. doi:10.1186/s40981-017-0143-0
    1. Kang BJ, Koh Y, Lim CM, et al. Failure of high‐flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med. 2015;41(4):623‐632. doi:10.1007/s00134-015-3693-5
    1. Lee M Jr, Nagler J. High‐flow nasal cannula therapy beyond the perinatal period. Curr Opin Pediatr. 2017;29(3):291‐296. doi:10.1097/MOP.0000000000000494
    1. Frat JP, Thille AW, Mercat A, et al. High‐flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185‐2196. doi:10.1056/NEJMoa1503326
    1. Betters KA, Gillespie SE, Miller J, Kotzbauer D, Hebbar KB. High flow nasal cannula use outside of the ICU; factors associated with failure. Pediatr Pulmonol. 2017;52(6):806‐812. doi:10.1002/ppul.23626
    1. Abboud PA, Roth PJ, Skiles CL, Stolfi A, Rowin ME. Predictors of failure in infants with viral bronchiolitis treated with high‐flow, high‐humidity nasal cannula therapy*. Pediatr Crit Care Med. 2012;13(6):e343‐e349. doi:10.1097/PCC.0b013e31825b546f
    1. Vareesunthorn I, Preutthipan A. Modified high‐flow nasal cannula in young children with pneumonia: a 3‐year retrospective study. Pediatr Respirol Crit Care Med. 2018;2(3):45‐50. doi:10.4103/prcm.prcm_2_18
    1. Kallappa C, Hufton M, Millen G, Ninan TK. Use of high flow nasal cannula oxygen (HFNCO) in infants with bronchiolitis on a paediatric ward: a 3‐year experience. Arch Dis Child. 2014;99(8):790‐791. doi:10.1136/archdischild-2014-306637
    1. Bressan S, Balzani M, Krauss B, Pettenazzo A, Zanconato S, Baraldi E. High‐flow nasal cannula oxygen for bronchiolitis in a pediatric ward: a pilot study. Eur J Pediatr. 2013;172(12):1649‐1656. doi:10.1007/s00431-013-2094-4
    1. Carter C, Aedy H, Notter J. COVID‐19 disease: non‐invasive ventilation and high frequency nasal oxygenation: clinics in integrated care. Clin Integr Care. 2020;100006. doi:10.1016/j.intcar.2020.100006 PMID: Epub 2020 Jul 17.
    1. Ohshimo S. Oxygen administration for patients with ARDS. J Intensive Care. 2021;9(1):1‐14. doi:10.1186/s40560-021-00532-0
    1. Drake MG. High‐flow nasal cannula oxygen in adults: an evidence‐based assessment. Ann Am Thorac Soc. 2018;15(2):145‐155. doi:10.1513/AnnalsATS.201707-548FR

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner